Mkts

Corcept Therapeutics Incorporated

NASDAQ: CORT
$67.79-2.28 (-3.25%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
67.0971.50
52-week range
28.66126.38
Today
Open70.91
Previous close67.79
Volume—
Valuation
Market cap7.67B
P/E ratio47.25×
EPS (TTM)1.29
Income & risk
Dividend / yield—
Beta0.66
Avg volume1.25M
Discussion

CORT News

Stories mentioning CORT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue164,903202,125207,638194,430157,214181,890182,546163,796
Cost of Goods Sold2,8832,5454,5963,4332,4032,9562,8672,524
Gross Profit162,020199,580203,042190,997154,811178,934179,679161,272
Operating Expenses
Research & Development66,26564,85668,84660,47160,73570,30159,33658,745
Sales General & Admin145,356130,237123,977103,85190,66083,37273,74566,935
Total Operating Expenses
Operating Income (Loss)(49,601)4,48710,21926,6753,41625,26146,59835,592
Interest Income
Interest Expense
Other Expense
Pretax Income(44,715)9,91015,24331,6929,61831,96152,94341,596
Tax Provision(12,954)(14,378)(4,425)(3,457)(10,929)1,2155,7306,108
Net Income (Loss)(31,761)24,28819,66835,14920,54730,74647,21335,488
Earnings Per Share (Basic)(0.30)0.230.190.330.190.300.450.34
Earnings Per Share (Diluted)(0.30)0.200.160.290.170.270.410.32
Weighted Average Shares Outstanding (Basic)104,435103,862103,545104,111104,106103,232103,371103,118
Weighted Average Shares Outstanding (Diluted)104,435119,987119,439120,485119,819113,480113,723111,244

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CORT

Corcept Therapeutics Incorporated (NASDAQ: CORT) is a stock listed on the Nasdaq Stock Market under the ticker symbol CORT. It last traded at $67.79 (Nov 18, 2026, 4:00 PM ET), down 3.3% on the day. That gives Corcept Therapeutics a market capitalisation of $7.7B and a price-to-earnings ratio of 47.3.

Over the past 52 weeks CORT has traded between $28.66 and $126.38.

Revenue for the quarter ended Mar 31, 2026 was $164.9M; a net loss of $31.8M. Revenue was up 4.9% from $157.2M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$164.9M-$31.8M-19.3%
Dec 31, 2025$202.1M$24.3M12.0%
Sep 30, 2025$207.6M$19.7M9.5%
Jun 30, 2025$194.4M$35.1M18.1%

From Corcept Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…